1
|
Ailhaud L, Gravier-Dumonceau R, Arregle F, Hubert S, Casalta JP, Riberi A, Tessonnier L, Giorgi R, Habib G, Gouriet F. Impact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis. Trop Med Infect Dis 2024; 9:86. [PMID: 38668547 DOI: 10.3390/tropicalmed9040086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2024] [Revised: 04/04/2024] [Accepted: 04/11/2024] [Indexed: 04/29/2024] Open
Abstract
BACKGROUND Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. OBJECTIVES The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. METHODS We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. RESULTS A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). CONCLUSIONS The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.
Collapse
Affiliation(s)
- Lucie Ailhaud
- Microbes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France
- IHU Méditerranée Infection, 13005 Marseille, France
| | - Robinson Gravier-Dumonceau
- BioSTIC, Department of Biostatistics and Information and Communication Technologies, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Florent Arregle
- Department of Cardiology, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Sandrine Hubert
- Department of Cardiology, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Jean-Paul Casalta
- Microbes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France
- IHU Méditerranée Infection, 13005 Marseille, France
| | - Alberto Riberi
- Department of Cardiac Surgery, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Laetitia Tessonnier
- Department of Nuclear Imagery, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Roch Giorgi
- BioSTIC, Department of Biostatistics and Information and Communication Technologies, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
- Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM), Institut de Recherche pour le Développement (IRD), Institut National de la Santé et de la Recherche médicale (INSERM), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France
| | - Gilbert Habib
- Microbes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France
- Department of Cardiology, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France
| | - Frédérique Gouriet
- Microbes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France
- IHU Méditerranée Infection, 13005 Marseille, France
| |
Collapse
|
2
|
Bele A, Wagh V, Munjewar PK. A Comprehensive Review on Cardiovascular Complications of COVID-19: Unraveling the Link to Bacterial Endocarditis. Cureus 2023; 15:e44019. [PMID: 37746510 PMCID: PMC10517725 DOI: 10.7759/cureus.44019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Accepted: 08/23/2023] [Indexed: 09/26/2023] Open
Abstract
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ushered in a new era of understanding the multifaceted nature of infectious diseases. Beyond its well-documented respiratory impact, COVID-19 has unveiled intricate interactions with the cardiovascular system, with potential implications that extend to bacterial endocarditis. This review explores the complex interplay between COVID-19 and bacterial endocarditis, elucidating shared risk factors, theoretical mechanisms, and clinical implications. We examine the diverse cardiovascular manifestations of COVID-19, ranging from myocarditis and thromboembolic events to arrhythmias, and delve into the pathogenesis, clinical features, and diagnostic challenges of bacterial endocarditis. By analyzing potential connections, such as viral-induced endothelial disruption and immune modulation, we shed light on the plausible relationship between COVID-19 and bacterial endocarditis. Our synthesis highlights the significance of accurate diagnosis, optimal management, and interdisciplinary collaboration in addressing the challenges posed by these intricate interactions. In addition, we underscore the importance of future research, emphasizing prospective studies on bacterial endocarditis incidence and investigations into the long-term cardiovascular effects of COVID-19. As the boundaries of infectious diseases and cardiovascular complications converge, this review calls for continued research, vigilance, and coordinated efforts to enhance patient care and public health strategies in a rapidly evolving landscape.
Collapse
Affiliation(s)
- Anurag Bele
- Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND
| | - Vasant Wagh
- Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND
| | - Pratiksha K Munjewar
- Medical Surgical Nursing, Smt. Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Higher Education and Research, Wardha, IND
| |
Collapse
|
3
|
Khedr A, Hassan EM, Hennawi HA, Jama AB, Khan MK, Mir M, Eissa A, Rauf I, Mushtaq H, Jain NK, Subla MR, Surani S, Khan SA. COVID-19-associated MRSA infective endocarditis and mitral valve perforation: a case report. Egypt Heart J 2023; 75:62. [PMID: 37464078 DOI: 10.1186/s43044-023-00392-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Accepted: 07/16/2023] [Indexed: 07/20/2023] Open
Abstract
BACKGROUND Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic, leading to significant morbidity and mortality. The interplay between COVID-19 and other medical conditions can complicate diagnosis and management, necessitating further exploration. CASE PRESENTATION This case report presents a patient with COVID-19 who developed infective endocarditis (IE) and mitral valve perforation caused by methicillin-resistant Staphylococcus aureus on a native mitral valve. Notably, the patient did not exhibit typical IE risk factors, such as intravenous drug use. However, he did possess risk factors for bacteremia, including a history of diabetes mellitus and recent steroid use due to the COVID-19 infection. The diagnosis of IE was crucially facilitated by transesophageal echocardiography. CONCLUSIONS This case highlights the potential association between COVID-19 and the development of infective endocarditis. Prompt evaluation using transesophageal echocardiography is vital when there is a high suspicion of IE in COVID-19 patients. Further research is required to elucidate the precise relationship between COVID-19 and IE.
Collapse
Affiliation(s)
| | | | | | | | - Muhammad Khuzzaim Khan
- Dow University of Health Sciences, Mission Rd, New Labour Colony Nanakwara, Karachi, 74200, Pakistan.
| | - Mikael Mir
- University of Minnesota Medical School, Minneapolis, MN, USA
| | - Aalaa Eissa
- Kafrelsheikh University Hospital, Kafr el-Sheikh, Egypt
| | - Ibtisam Rauf
- St. George's School of Medicine, University Centre Grenada, West Indies, Grenada
| | | | | | | | | | | |
Collapse
|